Bryan, Garnier & Co's News

Read all the news of the independent investment banking dedicated to Growth
Share on
Filters
Bryan, Garnier & Co acts as Joint Lead Manager and Joint Bookrunner of DBV $133m IPO on NASDAQ.

Bryan, Garnier & Co acts as Joint Lead Manager and Joint Bookrunner of DBV $133m IPO on NASDAQ.

Published last October Thursday 23, 2014

Voltalia: From Brazil with Love (full report published today)

BUY, Fair Value EUR11.5 (+38%)

Published last October Thursday 16, 2014

Bryan, Garnier & Co advised Keensight and Paris Orléans on the sale of FircoSoft to Reed Elsevier

Published last October Wednesday 15, 2014

Bryan, Garnier & Co supports the 2nd GreenUnivers & EnterNext Cleantech Conference in Paris.

Published last October Monday 13, 2014

DBV Technologies files for NASDAQ IPO, Bryan, Garnier & Co acting as joint bookrunner along with Citigroup and Leerink Partners.

Published last September Wednesday 24, 2014

Sanofi: Alirocumab delivers on promises

BUY, Fair Value EUR94 (+14%)

Published last September Monday 1, 2014

Ipsen Strong H1 results 10 questions for management

BUY, FV EUR41 vs. 36

Published last September Monday 1, 2014

Altran Technologies: Acquisition of Beyondsoft’s Telecoms R&D services activities in China

BUY, Fair Value EUR9.4 

Published last August Thursday 28, 2014

Luxury Goods: Tiffany : Q2 results above expectations

Published last August Thursday 28, 2014

Bureau Veritas: H1 results conference call: 2015 guidance lowered but already largely anticipated

BUY, Fair Value EUR24 vs. EUR26 (+21%)

Published last August Thursday 28, 2014

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities